Scoop: Moderna co-founder's regenerative medicine biotech nabs funds, but loses Genentech
Moderna co-founder Derrick Rossi is back with additional financing for a Cleveland biotech that he’s been working on since 2017, but Convelo Therapeutics is moving forward without a Big Pharma partner.
The retired Boston Children’s Hospital professor and his co-founders at Case Western Reserve University have raised nearly $11 million for Convelo in a new equity round, according to an SEC filing last week. Genentech is no longer part of the picture, though.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.